|
Abstract:
|
Rare safety events are difficult to evaluate in cases where sample sizes are small, studies have zero events in treatment arms, and meta-analytic methods vary. In this roundtable discussion, we will identify the shortcomings of standard statistical techniques, pros & cons of more advanced techniques, how well companies are prepared for unexpected rare safety signals, and how statisticians can communicate the risks to nonstatisticians.
|
